- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
FINN Partners Appoints Tom Jones to Lead New York Health Group and Pharma Sector Teams
The Promotion Recognizes Jones's Contributions to Agency Success and Practice Growth.
Global independent marketing and communications agency FINN Partners announced today that Tom Jones will lead its New York Health Group and Pharma Sector teams.
In his new role, Jones will continue to elevate the New York Health Group’s presence within the pharma sector and strengthen client relationships across North America. He also continues in his role leading the Global Practice Health Academy, the professional development institute within FINN that brings together colleagues’ best practices and market learnings worldwide.
“Joining FINN has been an incredible opportunity. My career now fully aligns with my personal and professional values – to prioritize the needs of patients, physicians and colleagues, which are foundational to success in this life-changing work,” said Jones. “My colleagues – many now working virtually around the world – are united by an understanding that we improve people’s health through our clients’ success. That understanding, shared by everyone involved at FINN, is creating winning work for clients.”
Beyond the Scrubs: Understanding Healthcare Providers as People for Increased Engagement
March 28th 2024The benefits of adopting a humanized approach to healthcare provider marketing extend across the healthcare spectrum, enhancing engagement rates, brand loyalty, and marketing ROI, while also driving better outcomes for patients.
Transforming Cancer Care: Data, AI, and Patient-Centered Care
July 20th 2023Join us as Mohit Manrao, SVP and head of US oncology at AstraZeneca, shares his patient-centered approach to transforming cancer care, bridging the gap between innovative science and tangible patient outcomes across all populations on a global scale.
